Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, November 7, 2026

Back to the front page

From X

@aleabitoreddit

Serenity on X

Good question! Just some informal thoughts... there's three "moats" to look at for $SIVE: - Capacity - Qualifications (especially for custom DFB lasers) - Technological 1. For capacity, they're coming online with 100M+ CW DFB lasers Q4 2027 (global supply is roughly ~608M EML/CW lasers currently per Trendforce). Obviously by 2027 global capacity is going to grow a lot, with $AAOI, $AVGO (3x expansion), and others coming online. But if you extrapolate their 2:1 statement, that implies 300m lasers/year long term coming from their own supply + external foundries. This is incredibly valuable during a shortage that was quoted to be 3-5 years, and $LITE stating they already have demand visibility into 2031... And when suppliers have started to qualify many more (eg. 5-7 vendors vs. 2-3 earlier) due to bottlenecks. I'm sure a lot of how they achieve that staggering amount is due to their manufacturing process/yields (which is a moat). 2. For qualifications, if you look at 70mW/100mW pluggable lines with Chinese players, I'd argue this is more generic and moreso reverting back to a capacity argument and manufacturing process to achieve those numbers. Custom DFB arrays that they've been working on with Ayar (they hinted at 2-3 others back in 2023 like Celestial) take years for optical i/o related things and would be a moat if they finish quals. So it's not quite something you can hot swap or design out really easily for $MTSI or another company. But of course cpo scale up and such is mass volume in 2028, and we're still H2 2026. 3. People can always compare raw specs like power output, but it's probably way way more nuanced so easier to just point toward customer statements. With $JBL 1.6T LRO: "I think that there's the potential for a relatively dramatic moat with our LRO part…" from Jabil's EVP, especially related to power consumption. And $SIVE is my guess sole source in this line. Jabil is probably the most important testament to how their lasers perform in mass production scenarios maybe around Q2 next year. Ayar said something similar along the lines of "we couldn't do it without Sivers" for custom implementations.
@aleabitoreddit

Serenity on X

Someone did ask “How is Serenity” this time around! So I’m happy. I’m just personally excited about $LITE selling out into 2029 and implications for optical peers like $AAOI. Not advice, but I personally think markets haven’t fully caught onto the scale of AOI’s ramp in 2027 + current bottleneck severity. It’s one of my largest positions right now for a reason! Also I’m looking forward to touching grass over the weekend. Apparently there was an OCP San Jose event… Maybe I’ll drop by if there’s a Kiss of Life group like at ICML.
@junkbondinvest

junkbondinvestor on X

Semafor out with a hitpiece on private credit. They lump the loans together without explaining one is senior and one is junior (both are first lien). But that's beyond the point. $FSK has a 1L loan to a distressed company marked at 98 cents (for reference, TCPC has it at 86 cents). Whatever, fine. And on the same company's JUNIOR tranche 1L debt? They have it marked at 10 cents. Both loans are PIK, already restructured once, and the equity is marked at ZERO. How do you justify a 98 cent mark on a company likely headed for bankruptcy, while simultaneously marking your junior debt at 10 cents? C'mon! Imagine this in public credit markets? This is the kind of shenanigans which makes no one trust PC marks.

Investor Letters

All letters

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

MDA $4.2B
Aurelion Research 4 clicks
AAP · long

Advance Auto Parts INC

Advance Auto Parts, AAP, is presented as a long idea following prior write-ups at $48.81 per share in January 2025.

AAP $2.9B
Value Investors Club 1 click

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 5 clicks

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…

STVN $3.6B
Best Anchor Stocks 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.